Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q1 2022 vs. Q4 2021

How the institutions holding Curis Inc changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of CRIS: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders134129−5
Shares71.6M64.7M−6.89M (−9.6%)
Value$340.9M$154.1M−$186.8M (−54.8%)

New holders (16)

Institutions that held Curis Inc at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CRIS in Q1 2022
InstitutionSharesValue% of portfolio
Marshall Wace, LLP1,448,677$3.45M0.01%
HRT Financial LP436,757$1.04M0.01%
Federated Hermes, Inc.283,744$675.0K0.00%
FMR LLC125,357$298.0K0.00%
Dimension Capital Management LLC110,000$262.0K0.05%
STRS Ohio68,100$162.0K0.00%
PDT Partners, LLC63,066$150.0K0.01%
The PNC Financial Services Group, Inc.60,291$143.0K0.00%
Bayesian Capital Management, LP32,400$77.0K0.01%
Boothbay Fund Management, LLC15,213$36.0K0.00%
Amalgamated Financial Corp.13,672$33.0K0.00%
Engineers Gate Manager LP13,315$32.0K0.00%
Paloma Partners Management Co10,773$26.0K0.00%
Walleye Trading LLC10,384$25.0K0.00%
WR Wealth Planners, LLC20$480.00%
IFP Advisors, Inc100––

Sold out (21)

Institutions that held Curis Inc at the end of Q4 2021 and filed for Q1 2022 without it.